A new genetic target for Alzheimer’s treatments

About Us CRU Directors CRU Investigators Leading Trial Site Clinical Trials Information for Patients ALS Brain Tumour Dementia Epilepsy Intensive Care Unit Movement Disorders Multiple Sclerosis Neuromuscular Stroke ASHG SYMPOSIUM Program Abstracts Registration...

A look back at the advances of 2024

About Us CRU Directors CRU Investigators Leading Trial Site Clinical Trials Information for Patients ALS Brain Tumour Dementia Epilepsy Intensive Care Unit Movement Disorders Multiple Sclerosis Neuromuscular Stroke ASHG SYMPOSIUM Program Abstracts Registration...

Can Alzheimer’s disease be stopped before it starts?

About Us CRU Directors CRU Investigators Leading Trial Site Clinical Trials Information for Patients ALS Brain Tumour Dementia Epilepsy Intensive Care Unit Movement Disorders Multiple Sclerosis Neuromuscular Stroke ASHG SYMPOSIUM Program Abstracts Registration...

2023 Year in Review: Driving research in rare disease

2023: The CRU driving new research in rare disease  Sophie LorenzoDecember 19, 2023   As a leading Canadian centre in neurological research, the Clinical Research Unit (CRU) at The Neuro is always striving to make neurological and rare diseases treatable – and...

A new chapter in Alzheimer’s research

About Us CRU Directors CRU Investigators Leading Trial Site Clinical Trials Information for Patients ALS Brain Tumour Dementia Epilepsy Intensive Care Unit Movement Disorders Multiple Sclerosis Neuromuscular Stroke ASHG SYMPOSIUM Program Abstracts Registration...